Kolltan Pharmaceuticals Inc. To Present At The Stifel 2015 Healthcare Conference

NEW HAVEN, Conn.--(BUSINESS WIRE)--Kolltan Pharmaceuticals, Inc., a privately held clinical-stage company focused on the discovery and development of novel antibody-based drugs targeting receptor tyrosine kinases, today announced that management will provide a corporate overview and business update, including anticipated key milestones, at the Stifel 2015 Healthcare Conference on Wednesday, November 18, 2015. The conference will be held at the Palace Hotel in New York, NY.

Help employers find you! Check out all the jobs and post your resume.